Imatinib Mesylate — Carefirst Caremark
15 indications indexed for this drug.
- Acute Lymphoblastic Leukemia All Or Lymphoblastic Lymphoma LView coverage criteria
- Aggressive Systemic Mastocytosis AsmView coverage criteria
- ChordomaView coverage criteria
- Chronic Eosinophilic Leukemia CelView coverage criteria
- Chronic Graft Versus Host Disease CgvhdView coverage criteria
- Chronic Myeloid Leukemia CmlView coverage criteria
- Cutaneous MelanomaView coverage criteria
- Dermatofibrosarcoma Protuberans DfspView coverage criteria
- Desmoid TumorsView coverage criteria
- Gastrointestinal Stromal Tumor GistView coverage criteria
- Hypereosinophilic Syndrome HesView coverage criteria
- Kaposi SarcomaView coverage criteria
- Myelodysplastic Syndromes Myeloproliferative Diseases Mds MpView coverage criteria
- Myeloid Lymphoid Neoplasms With EosinophiliaView coverage criteria
- Pigmented Villonodular Synovitis Tenosynovial Giant Cell TumView coverage criteria